{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T23:25:27Z","timestamp":1784417127269,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75728-z","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T11:02:43Z","timestamp":1729681363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inappropriate ceftriaxone utilization and predictor factors in Ethiopia: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Chernet","family":"Tafere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destaw","family":"Endeshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn Getnet","family":"Demsie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malede Berihun","family":"Yismaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bereket Bahiru","family":"Tefera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adane","family":"Yehualaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede","family":"Feyisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim Abdela","family":"Siraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashagrachew Tewabe","family":"Yayehrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenaw Debasu","family":"Addisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousman","family":"Adal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"issue":"10","key":"75728_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045805","volume":"11","author":"SG Tassew","year":"2021","unstructured":"Tassew, S. G., Abraha, H. N., Gidey, K. & Gebre, A. K. Assessment of drug use pattern using WHO core drug use indicators in selected general hospitals: A cross-sectional study in Tigray region, Ethiopia. BMJ Open 11(10), e045805 (2021).","journal-title":"BMJ Open"},{"key":"75728_CR2","unstructured":"WHO. Rational use of medicines by prescribers and patients. Report by the secretariat. 16 (2004)."},{"issue":"1","key":"75728_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12911-021-01530-w","volume":"21","author":"TF Wendie","year":"2021","unstructured":"Wendie, T. F., Ahmed, A. & Mohammed, S. A. Drug use pattern using WHO core drug use indicators in public health centers of Dessie, North-East Ethiopia. BMC Med. Inf. Decis. Mak. 21(1), 197 (2021).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"75728_CR4","doi-asserted-by":"crossref","unstructured":"Mamo, D. B. & Alemu, B. K. Rational drug-use evaluation based on World Health Organization core drug-use indicators in a tertiary referral hospital, Northeast Ethiopia: A cross-sectional Study. Drug Healthc. Patient Saf. 15\u201321. (2020).","DOI":"10.2147\/DHPS.S237021"},{"key":"75728_CR5","volume-title":"The Pursuit of Responsible Use of Medicines: Sharing and Learning from Country Experiences","author":"WHO","year":"2012","unstructured":"WHO. The Pursuit of Responsible Use of Medicines: Sharing and Learning from Country Experiences (World Health Organization, 2012)."},{"issue":"10","key":"75728_CR6","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.18203\/2349-2902.isj20194413","volume":"6","author":"N Soman","year":"2019","unstructured":"Soman, N., Panda, B. K., Banerjee, J. & John, S. M. A study on prescribing pattern of cephalosporins utilization and its compliance towards the hospital antibiotic policy in surgery ward of a tertiary care teaching hospital in India. Int. Surg. J. 6(10), 3614\u20133621 (2019).","journal-title":"Int. Surg. J."},{"issue":"1","key":"75728_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/0018578717737429","volume":"53","author":"S Girma","year":"2018","unstructured":"Girma, S., Sisay, M., Mengistu, G., Amare, F. & Edessa, D. Antimicrobial utilization pattern in pediatric patients in tertiary care hospital, Eastern Ethiopia: The need for antimicrobial stewardship. Hosp. Pharm. 53(1), 44\u201354 (2018).","journal-title":"Hosp. Pharm."},{"key":"75728_CR8","doi-asserted-by":"crossref","unstructured":"Sileshi, A., Tenna, A., Feyissa, M. & Shibeshi. W. Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: A prospective cross-sectional study (2016).","DOI":"10.1186\/s40360-016-0057-x"},{"key":"75728_CR9","unstructured":"Sasi, P., Mwakyandile, T., Manyahi, J., Kunambi, P., Mugusi, S. & Rimoy, G. Ceftriaxone prescribing and resistance pattern at a national hospital in Tanzania (2020)."},{"key":"75728_CR10","doi-asserted-by":"crossref","unstructured":"Menkem, E. Z., Labo Nanfah, A., Takang, T., Ryan Awah, L., Awah Achua, K., Ekane Akume, S. et al. Attitudes and practices of the use of third-generation cephalosporins among medical doctors practicing in Cameroon. Int. J. Clin. Pract. 2023 (2023).","DOI":"10.1155\/2023\/8074413"},{"key":"75728_CR11","volume-title":"Promoting Rational Use of Medicines: Core Components","author":"WHO","year":"2002","unstructured":"WHO. Promoting Rational Use of Medicines: Core Components (World Health Organization, 2002)."},{"issue":"4","key":"75728_CR12","first-page":"266","volume":"14","author":"MJS Rehman","year":"2019","unstructured":"Rehman, M. J. S., Alrowaili, M., Rauf, A. W. A. & Eltom, E. H. Ceftriaxone drug utilization evaluation (DUE) at Prince Abdulaziz Bin Moussae\u2019ed Hospital, Arar, Kingdom of Saudi Arabia. Sudan J. Med. Sci. 14(4), 266\u2013275 (2019).","journal-title":"Sudan J. Med. Sci."},{"issue":"4","key":"75728_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3904\/kjim.2009.24.4.374","volume":"24","author":"H Lee","year":"2009","unstructured":"Lee, H. et al. Evaluation of ceftriaxone utilization at multicenter study. Korean J. Int. Med. 24(4), 374 (2009).","journal-title":"Korean J. Int. Med."},{"key":"75728_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).","journal-title":"BMJ"},{"issue":"2","key":"75728_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein, M., Hedges, L. V., Higgins, J. P. & Rothstein, H. R. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res. Synth. Methods 1(2), 97\u2013111 (2010).","journal-title":"Res. Synth. Methods"},{"key":"75728_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-8-79","volume":"8","author":"G R\u00fccker","year":"2008","unstructured":"R\u00fccker, G., Schwarzer, G., Carpenter, J. R. & Schumacher, M. Undue reliance on I 2 in assessing heterogeneity may mislead. BMC Med. Res. Methodol. 8, 1\u20139 (2008).","journal-title":"BMC Med. Res. Methodol."},{"key":"75728_CR17","doi-asserted-by":"crossref","unstructured":"Higgins, J. P. & Green, S. Cochrane handbook for systematic reviews of interventions (2008).","DOI":"10.1002\/9780470712184"},{"key":"75728_CR18","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s11606-018-4425-7","volume":"33","author":"L Lin","year":"2018","unstructured":"Lin, L. et al. Empirical comparison of publication bias tests in meta-analysis. J. General Int. Med. 33, 1260\u20131267 (2018).","journal-title":"J. General Int. Med."},{"key":"75728_CR19","unstructured":"Wells, G. A., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (2000)."},{"issue":"2","key":"75728_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.gie.2020.10.007","volume":"93","author":"BJ Qumseya","year":"2021","unstructured":"Qumseya, B. J. Quality assessment for systematic reviews and meta-analyses of cohort studies. Gastrointest. Endosc. 93(2), 486\u201394 (2021).","journal-title":"Gastrointest. Endosc."},{"key":"75728_CR21","unstructured":"FMHACA. Standard Treatment Guidelines for General Hospital. FMHACA Addis Ababa, Ethiopia (2014)."},{"key":"75728_CR22","doi-asserted-by":"crossref","unstructured":"Gelaw, L. Y., Bitew, A. A., Gashey, E. M. & Ademe, M. N. Ceftriaxone resistance among patients at GAMBY teaching general hospital. Sci. Rep. 12(1) (2022).","DOI":"10.1038\/s41598-022-16132-3"},{"key":"75728_CR23","unstructured":"Drug use evaluation of ceftriaxone at Adama Hospital Medical College medical WARD, Adama, Ethiopia 2015 [Internet]. 2015 [cited 4\/15\/2024]. Available from: https:\/\/www.coursehero.com\/file\/220942727\/ceftriaxonedocx\/."},{"key":"75728_CR24","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.2147\/IDR.S381999","volume":"15","author":"AW Garedow","year":"2022","unstructured":"Garedow, A. W. & Tesfaye, G. T. Evaluation of antibiotics use and its predictors at pediatrics ward of Jimma Medical Center: Hospital based prospective cross-sectional study. Infect. Drug Resist. 15, 5365\u20135375 (2022).","journal-title":"Infect. Drug Resist."},{"key":"75728_CR25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/IDR.S251151","volume":"13","author":"M Mama","year":"2020","unstructured":"Mama, M. et al. Inappropriate antibiotic use among inpatients attending Madda Walabu University Goba Referral Hospital, Southeast Ethiopia: Implication for future use. Infect. Drug Resist. 13, 1403\u20131409 (2020).","journal-title":"Infect. Drug Resist."},{"issue":"7","key":"75728_CR26","first-page":"2191","volume":"3","author":"FA Abebe","year":"2012","unstructured":"Abebe, F. A., Berhe, D. F., Berhe, A. H., Hishe, H. Z. & Akaleweld, M. A. Drug use evaluation of ceftriaxone: The case of Ayder Referral Hospital, Mekelle, Ethiopia. Int. J. Pharm. Sci. Res. 3(7), 2191 (2012).","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"75728_CR27","doi-asserted-by":"publisher","first-page":"205031212110515","DOI":"10.1177\/20503121211051525","volume":"9","author":"F Amare","year":"2021","unstructured":"Amare, F., Gashaw, T., Sisay, M., Baye, Y. & Tesfa, T. The appropriateness of ceftriaxone utilization in government hospitals of Eastern Ethiopia: A retrospective evaluation of clinical practice. SAGE Open Med. 9, 20503121211051524 (2021).","journal-title":"SAGE Open Med."},{"key":"75728_CR28","doi-asserted-by":"crossref","unstructured":"Ayele, A. A., Gebresillassie, B. M., Erku, D. A., Gebreyohannes, E. A., Demssie, D. G., Mersha, A. G. et al. Prospective evaluation of Ceftriaxone use in medical and emergency wards of Gondar university referral hospital, Ethiopia. Pharmacol. Res. Perspect. 6(1) (2018).","DOI":"10.1002\/prp2.383"},{"issue":"6","key":"75728_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.5455\/2319-2003.ijbcp20131208","volume":"2","author":"GA Ayinalem","year":"2013","unstructured":"Ayinalem, G. A., Gelaw, B. K., Belay, A. Z. & Linjesa, J. L. Drug use evaluation of ceftriaxone in medical ward of Dessie Referral Hospital, North East Ethiopia. Int. J. Basic Clin. Pharmacol. 2(6), 711\u2013717 (2013).","journal-title":"Int. J. Basic Clin. Pharmacol."},{"key":"75728_CR30","first-page":"671","volume":"4","author":"L Bantie","year":"2014","unstructured":"Bantie, L. Drug use evaluation (DUE) of Ceftriaxone injection in the in-patient wards of Felege Hiwot Referral Hospital (FHRH), Bahir Dar, North Ethiopia. Int. J. Pharm. Sci. 4, 671\u2013676 (2014).","journal-title":"Int. J. Pharm. Sci."},{"key":"75728_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4172\/1948-593X.1000221","volume":"10","author":"G Geresu","year":"2018","unstructured":"Geresu, G., Yadesa, T. & Deresa, B. Drug use evaluation of ceftriaxone in medical ward of Mizan Aman general hospital, Bench Maji Zone, South Western Ethiopia. J. Bioanal. Biomed. 10, 127\u2013131 (2018).","journal-title":"J. Bioanal. Biomed."},{"key":"75728_CR32","first-page":"26","volume":"2","author":"K Hafte","year":"2018","unstructured":"Hafte, K., Tefera, K., Azeb, W., Yemsrach, W. & Ayda, R. Assessment of ceftriaxone use in Eastern Ethiopian Referral Hospital: A retrospective study. J. Infect. Dis. Med. Microbiol. 2, 26\u201329 (2018).","journal-title":"J. Infect. Dis. Med. Microbiol."},{"key":"75728_CR33","volume-title":"Evaluation of Ceftriaxone Utilization and Prescriber\u2019s Opinion at Armed Forces Referral and Teaching Hospital, Addis Ababa","author":"K Mehari","year":"2017","unstructured":"Mehari, K. Evaluation of Ceftriaxone Utilization and Prescriber\u2019s Opinion at Armed Forces Referral and Teaching Hospital, Addis Ababa (Addis Ababa University, 2017)."},{"key":"75728_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/DHPS.S260364","volume":"12","author":"OS Muhammed","year":"2020","unstructured":"Muhammed, O. S. & Nasir, B. B. Drug use evaluation of ceftriaxone in Ras-Desta Memorial General Hospital, Ethiopia. Drug Healthc. Patient Saf 12, 161\u2013168 (2020).","journal-title":"Drug Healthc. Patient Saf"},{"key":"75728_CR35","first-page":"26","volume":"3","author":"N Sewagegn","year":"2017","unstructured":"Sewagegn, N. et al. Evaluation of ceftriaxone use for hospitalized patients in Ethiopia: The case of a referral hospital. Int. J. Pharm. Sci. Sci. Res. 3, 26\u201331 (2017).","journal-title":"Int. J. Pharm. Sci. Sci. Res."},{"key":"75728_CR36","doi-asserted-by":"crossref","unstructured":"Shegute, T., Hiruy, M., Hadush, H. & Gebremeskel, L. Ceftriaxone use evaluation in Western Zone Tigray Hospitals, Ethiopia: A retrospective cross-sectional study. BioMed. Res. Int. 2023 (2023).","DOI":"10.1155\/2023\/7688896"},{"issue":"26","key":"75728_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40545-015-0047-1","volume":"8","author":"T Shimels","year":"2015","unstructured":"Shimels, T., Bilal, A. I. & Mulugeta, A. Evaluation of ceftriaxone utilization in internal medicine wards of general hospitals in Addis Ababa, Ethiopia: A comparative retrospective study. J. Pharm. Policy Pract. 8(26), 26 (2015).","journal-title":"J. Pharm. Policy Pract."},{"issue":"2","key":"75728_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4314\/epj.v31i2.6","volume":"31","author":"T Shimels","year":"2015","unstructured":"Shimels, T. & Fenta, T. G. Assessment of ceftriaxone utilization in different wards of the federal police referral hospital in Ethiopia: A retrospective study. Ethiop. Pharm. J. 31(2), 141\u2013150 (2015).","journal-title":"Ethiop. Pharm. J."},{"issue":"3","key":"75728_CR39","first-page":"7","volume":"12","author":"D Taressa","year":"2021","unstructured":"Taressa, D., Sosengo, T., Abera Jambo, E. M., Abdella, J. & Amare, F. Appropriateness of ceftriaxone prescription: A case of Haramaya hospital Eastern Ethiopia. J. Basic Clin. Pharm. 12(3), 7 (2021).","journal-title":"J. Basic Clin. Pharm."},{"issue":"1","key":"75728_CR40","first-page":"41221","volume":"50","author":"A Werede","year":"2023","unstructured":"Werede, A. et al. Drug use evaluation study of ceftriaxone in Ras Desta Damtew Memorial Hospital 2022 GC. Biomed. J. Sci Tech. Res. Soc. Dev. 50(1), 41221\u20136 (2023).","journal-title":"Biomed. J. Sci Tech. Res. Soc. Dev."},{"key":"75728_CR41","doi-asserted-by":"crossref","unstructured":"Jifar, W. W., Adugna, D., Gadisa, B., Debele, G. R. & Admasu, T. T. Retrospective drug use evaluation of ceftriaxone in resource limited setting in case of Bedele General Hospital, Ethiopia. pp 1\u201314 (2022).","DOI":"10.21203\/rs.3.rs-2315263\/v1"},{"issue":"4","key":"75728_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41433-021-01867-6","volume":"36","author":"Y Chang","year":"2022","unstructured":"Chang, Y. et al. The 5 min meta-analysis: Understanding how to read and interpret a forest plot. Eye 36(4), 673\u2013675 (2022).","journal-title":"Eye"},{"key":"75728_CR43","doi-asserted-by":"crossref","unstructured":"Deeks, J. J., Higgins, J. P., Altman, D. G. & Group, C. S. M. Analysing data and undertaking meta\u2010analyses. Cochrane handbook for systematic reviews of interventions. pp 241\u201384 (2019).","DOI":"10.1002\/9781119536604.ch10"},{"issue":"5","key":"75728_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ejvs.2010.07.011","volume":"40","author":"MJ Bown","year":"2010","unstructured":"Bown, M. J. & Sutton, A. J. Quality control in systematic reviews and meta-analyses. Eur. J. Vasc. Endovasc. Surg. 40(5), 669\u2013677 (2010).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"7","key":"75728_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/antibiotics10070779","volume":"10","author":"P Kutyabami","year":"2021","unstructured":"Kutyabami, P. et al. Evaluation of the clinical use of ceftriaxone among in-patients in selected health facilities in Uganda. Antibiotics 10(7), 779 (2021).","journal-title":"Antibiotics"},{"key":"75728_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4087-z","volume":"19","author":"YH Berhe","year":"2019","unstructured":"Berhe, Y. H., Amaha, N. D. & Ghebrenegus, A. S. Evaluation of ceftriaxone use in the medical ward of Halibet National Referral and teaching hospital in 2017 in Asmara, Eritrea: A cross sectional retrospective study. BMC Infect. Dis. 19, 1\u20137 (2019).","journal-title":"BMC Infect. Dis."},{"key":"75728_CR47","doi-asserted-by":"crossref","unstructured":"Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane database of systematic reviews. 2013(4).","DOI":"10.1002\/14651858.CD003543.pub3"},{"issue":"9","key":"75728_CR48","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/pathogens12091074","volume":"12","author":"E Cella","year":"2023","unstructured":"Cella, E. et al. Joining forces against antibiotic resistance: The one health solution. Pathogens 12(9), 1074 (2023).","journal-title":"Pathogens"},{"key":"75728_CR49","doi-asserted-by":"crossref","unstructured":"Salam, A., Al-Amin, Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A. et al. editors. Antimicrobial resistance: A growing serious threat for global public health. Healthcare MDPI (2023).","DOI":"10.20944\/preprints202305.0555.v1"},{"issue":"6","key":"75728_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/8755122517720293","volume":"33","author":"SH Durham","year":"2017","unstructured":"Durham, S. H., Wingler, M. J. & Eiland, L. S. Appropriate use of ceftriaxone in the emergency department of a Veteran\u2019s health care system. J. Pharm. Technol. 33(6), 215\u2013218 (2017).","journal-title":"J. Pharm. Technol."},{"key":"75728_CR51","first-page":"4757","volume":"7","author":"M Malik","year":"2020","unstructured":"Malik, M. et al. Evaluation of the appropriate use of ceftriaxone in internal medicine wards of Wad Medani Teaching Hospital in Sudan. Int. J. Med. Sci. Clin. Invent. 7, 4757\u20134765 (2020).","journal-title":"Int. J. Med. Sci. Clin. Invent."},{"issue":"2","key":"75728_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/antibiotics12020288","volume":"12","author":"A Gorgulho","year":"2023","unstructured":"Gorgulho, A. et al. Appropriateness of empirical prescriptions of ceftriaxone and identification of opportunities for stewardship interventions: A single-centre cross-sectional study. Antibiotics 12(2), 288 (2023).","journal-title":"Antibiotics"},{"issue":"3","key":"75728_CR53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1086\/519283","volume":"45","author":"JC McGregor","year":"2007","unstructured":"McGregor, J. C. et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin. Infect. Dis. 45(3), 329\u2013337 (2007).","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"75728_CR54","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan, R. et al. Antibiotic resistance\u2014the need for global solutions. Lancet Infect. Dis. 13(12), 1057\u20131098 (2013).","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"75728_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13756-017-0208-x","volume":"6","author":"JA Ayukekbong","year":"2017","unstructured":"Ayukekbong, J. A., Ntemgwa, M. & Atabe, A. N. The threat of antimicrobial resistance in developing countries: Causes and control strategies. Antimicrob. Resist. Infect. Control 6(1), 47 (2017).","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"3","key":"75728_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1021\/acsptsci.0c00027","volume":"3","author":"Z Dhesi","year":"2020","unstructured":"Dhesi, Z., Enne, V. I., O\u2019Grady, J., Gant, V. & Livermore, D. M. Rapid and point-of-care testing in respiratory tract infections: an antibiotic guardian?. ACS Pharmacol. Transl. Sci. 3(3), 401\u201317 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"50","key":"75728_CR57","first-page":"18","volume":"18","author":"E Castro-S\u00e1nchez","year":"2023","unstructured":"Castro-S\u00e1nchez, E., Group WARNIN. Ten golden rules for optimal antibiotic use in hospital settings: The WARNING call to action. World J. Emerg. Surg. 18(50), 18\u201330 (2023).","journal-title":"World J. Emerg. Surg."},{"issue":"1","key":"75728_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13756-022-01096-w","volume":"11","author":"J Janssen","year":"2022","unstructured":"Janssen, J. et al. Exploring the economic impact of inappropriate antibiotic use: The case of upper respiratory tract infections in Ghana. Antimicrob. Resist. Infect. Control. 11(1), 53 (2022).","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"75728_CR59","doi-asserted-by":"crossref","unstructured":"Altaf, U., Saleem, Z., Akhtar, M. F., Altowayan, W. M., Alqasoumi, A. A., Alshammari, M. S. et al. Using culture sensitivity reports to optimize antimicrobial therapy: Findings and implications of antimicrobial stewardship activity in a hospital in Pakistan. Medicina (Kaunas) 59(7). (2023).","DOI":"10.3390\/medicina59071237"},{"issue":"1","key":"75728_CR60","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2021.210","volume":"1","author":"NJ Tinker","year":"2021","unstructured":"Tinker, N. J. et al. Interventions to optimize antimicrobial stewardship. Antimicrob Steward Healthc. Epidemiol. 1(1), e46 (2021).","journal-title":"Antimicrob Steward Healthc. Epidemiol."},{"key":"75728_CR61","doi-asserted-by":"crossref","unstructured":"Abejew, A. A., Wubetu, G. Y. & Fenta, T. G. Assessment of challenges and opportunities in antibiotic stewardship program implementation in Northwest Ethiopia. Heliyon (2024).","DOI":"10.1016\/j.heliyon.2024.e32663"},{"issue":"1","key":"75728_CR62","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s40545-023-00634-0","volume":"16","author":"MT Boltena","year":"2023","unstructured":"Boltena, M. T. et al. Adherence to evidence-based implementation of antimicrobial treatment guidelines among prescribers in sub-Saharan Africa: A systematic review and meta-analysis. J. Pharm. Policy Pract. 16(1), 137 (2023).","journal-title":"J. Pharm. Policy Pract."},{"key":"75728_CR63","doi-asserted-by":"crossref","unstructured":"Gorgulho, A., Cunha, F., Alves Branco, E., Azevedo, A., Almeida, F., Duro, R. et al. Appropriateness of empirical prescriptions of ceftriaxone and identification of opportunities for stewardship interventions: A single-centre cross-sectional study. Antibiotics (Basel) 12(2) (2023).","DOI":"10.3390\/antibiotics12020288"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75728-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T11:08:55Z","timestamp":1729681735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75728-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75728"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75728-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"25035"}}